Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study

Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study

<p>Abstract</p> <p>Background</p> <p>The optimal duration of clopidogrel treatment after percutaneous coronary intervention (PCI) is unclear. We studied the risk of death or recurrent myocardial infarction (MI) in relation to 6- and 12-months clopidogrel treatment among...

Full description

Bibliographic Details
Main Authors: Køber Lars, Abildgaard Ulrik, Madsen Jan K, Hansen Peter R, Hansen Morten L, Fosbøl Emil L, Folke Fredrik, Weeke Peter, Abildstrom Steen Z, Sørensen Rikke, Poulsen Henrik E, Torp-Pedersen Christian, Gislason Gunnar H
Format: Article
Language:English
Published: BMC 2010-01-01
Series:BMC Cardiovascular Disorders
Online Access:http://www.biomedcentral.com/1471-2261/10/6

Internet

http://www.biomedcentral.com/1471-2261/10/6

Similar Items